Mount Sinai Health System prioritizes the value of AI beyond just financial gain, with a unique leadership structure and focus on ethical implementation.

During the third quarter of fiscal year 2025 (“Q3 FY2025”) and to date in 2025, HeartSciences has seen material progress towards FDA submissions of our products and there have been significant ...

As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused ...

As healthcare organizations seek to improve efficiency and accuracy in medical coding, many are exploring AI-driven solutions ...

In response, Cogito Tech has launched DataSum, a certification framework designed to make AI data sourcing more transparent ...

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

CORRECTION: Canaccord Genuity was involved in the placement of only a portion, not all, of the 14 million shares ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...

Newsweek connected with the leaders of some of the top U.S. health care systems to identify key features that make a hospital great.